Acceptability of self-taken vaginal for early detection of HPV DNA in women with limited access to health services: An alternative to increase the coverage in a state of the Mexican Republic

Terán-Figueroa Yolanda, Muñiz-Carreón Patricia, Gallegos-Arévalo Yolanda Graciela, Gaytán-Hernández Darío, Gutiérrez-Enríquez Sandra Olimpia

Faculty of Nurse and Nutriology, Autonomic University of Chihuahua, Chihuahua, México.
Nursing Faculty, Autonomic University of San Luis Potosí, San Luis Potosí, México.
Nursing Faculty, Autonomic University of San Luis Potosí, San Luis Potosí, México;.

DOI: 10.4236/health.2013.512295                

Abstract

Objective: To determine the acceptability of self-taken vaginal to detect HPV DNA in women living in marginalized areas as an alternative to increase the coverage of health services. Methods: A cross-sectional study from March 2009 to April 2011 in 20 municipalities with the highest marginalization in the Huasteca Region of the State of San Luis Potosi, México. We applied a non-probabilistic quota sampling, which was composed of 608 women aged 25 years and more. The recruitment of women was performed through loudspeakers, leaflets and community meetings. A survey consisted of two sections: socio-demographic data and risk factors, which was validated by construct. We checked the reliability by Cronbach’s Alpha (0.90). Acceptability was determined by considering three indicators: perceived comfort, acceptability of the test and the reasons of acceptability. Results: 41.4% of this woman had 31-40 years. 70.5% were married. 35.3% finished high school and 6.7% had not education experience. 67.4% began their sexual life at 18 years or younger. 85.5% preferred self-collection and 14.5% Pap. These results show a clear acceptability of self-making on the other screening method. Regarding the reason for the preference is that 99.4% of women prefer self-take because they feel more comfortable compared to 0.6% who prefer the Papanicolaou. On the perception of comfort 91% mentioned feel very comfortable with self-making compared with 9% of Pap. There was a statisti

cally significant correlation between preference reasons that women have to choose the screening test and the perception of comfort (X²p = 0.000). Conclusions: The self-taken vaginal HPV DNA detection is a well accepted method in women who live in marginalized areas; therefore, it is an alternative that can be considered in the uterine cancer detection testing program.

 

Keywords

Self-Taken Vaginal HPV; Cervical Cancer; Acceptability of Self-Making

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Alterio, G., Mendoza, I., Mendoza, R., Peraza, E., Pérez, H. and Sánchez, A. (2007) Cytological findings and pathology risk factors for preinvasive and invasive cervical cancer. Area of influence of urban ambulatory type II. Revista Public Health and Nutrition, 8, 1-29. http://www.respyn.uanl.mx/index.html
[2]	López, A. and Lizano, M. (2006) Cervical cancer and human papilloma virus that does not end the story. Journal of the National Cancer Institute Mexico, 1, 31-55.
[3]	Castellano, M.R. (2003) Cervical cancer and HPV. Detection options. Revista de la Facultad de Medicina, 46, 63-65.
[4]	Ferlay, J., Bray, F., Pisani, P. and Parkin, D.M. (2000) GLOBOCAN: Cáncer, incidence, mortality and prevalence worldwide. Versión 1.0. IARC Cancer Base No. 5. Lyon: IARC. http://onlinelibrary.wiley.com/doi/10.1002/ijc.25516/full
[5]	Government of México (2007) National Institute of Statistics, Geography and Informatics. Morbidity and mortality statistics by state. INEGI, Mexico DF.
[6]	Lewis, M.J. (2004) Situational analysis of cervical cancer in Latin America and the Caribbean. Pan American Health Organization/World Health Organization (OPS/ OMS), 1-33.
[7]	Lazcano-Ponce, E.C., Castro, R., Allen, B., Nájera-Aguilar, P., Alonso-de-Ruiz, P. and Hernández-ávila, M. (1999) Barriers to early detection of cervical uterine cancer in Mexico. Journal of Women’s Health, 8, 399-408. http://dx.doi.org/10.1089/jwh.1999.8.399
[8]	Cox, J.T., Lorincz, A.T., Schiffman, M.H., Sherman, M.E., Cullen, A. and Kurman, R.J. (1995) Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. American Journal of Obstetrics & Gynecology, 172, 946-954. http://dx.doi.org/10.1016/0002-9378(95)90026-8
[9]	Snijders, P. (2011) Milestones in a decision process. HPV Today Newsletter of Human Papillomavirus. Holland Special Edition. www.hpvtoday.com
[10]	Gok, M., van Kemenade, F.J., Heideman, D.A., Berkhor, J., Rozendaal, L., Spruyt, J.W., et al. (2010) HPV testing on self-collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: Cohort study. BMJ, 340, c1040. http://dx.doi.org/10.1136/bmj.c1040
[11]	Sanner, K., Wilkstrom, I., Strand, A., Lindell, M. and Wilander, E. (2009) Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. British Journal of Cancer, 101, 871-874. http://dx.doi.org/10.1038/sj.bjc.6605194
[12]	Gok, M., van Kemenade, F.J., Heideman, D.A., Berkhof, J., Rozendaal, L., Spruyt, J.W., et al. (2012) Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. International Journal of Cancer, 130, 1128-1135. http://dx.doi.org/10.1002/ijc.26128
[13]	García Rodríguez, M.C. (2011) Structure, organization and prospects of the State Program for Cervical Cancer. In: Gallegos-García, V., Gutiérrez-Enríquez, S.O., TeránFigueroa, Y. and Velázquez-Mota, G.P., Eds., Experiences in the Implementation of the Programme of Cervical Cancer Screening, Editorial Universidad Autónoma de San Luis Potosí, San Luis Potosí, 33-37.
[14]	Instituto Nacional de Salud Pública (2008) Programme for early detection of cervical cancer with HPV testing: Morelos. Organization and Procedures Manual. Cuernavaca Morelos, 24.
[15]	Khan, M.J., Partridge, E.E., Wang, S.S. and Schiffman, M. (2005) Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer, 104, 61-70. http://dx.doi.org/10.1002/cncr.21129
[16]	Serrano, R.O., Pérez, C.J.U., Martínez, L.A.D. and Romero, Y.R.D. (2004) Risk factors for uterine cervical cancer. Revista Colombiana de Obstetricia y Ginecología, 55, 146-160.
[17]	álvarez, M., Chiarello, A., Espinal, E., Reigosa, A. and Marrero, M. (2010) Detection of human papillomavirus (HPV) in a group of patients with clinical and/or pathological infection by VPH. Salud Rev de la Facultad de Ciencias de la Salud. Universidad de Carabobo, 4, 19-26.
[18]	Torres-Poveda, K.J., Arredondo-López, A.A., Duarte-Gómez, M.A. and Madrid-Marina, V. (2008) The indigenous women vulnerable to cervical cancer: Perspectives from conceptual models of public health. Revista Salud en Tabasco, 14, 807-815.
[19]	Heideman, D.A.M. (2012) Auto-sampling in cervical screening programs: Current practice to future practice. HPV Today Newsletter of Human Papillomavirus, Holland Special Edition, 24, 10-11.
[20]	Szarewski, A., Cadman, L., Mesher, D., Austin, J., Ashdown-Barr, L., Edwards, R., Lyons, D., et al. (2011) HPV self-sampling as an alternative strategy in non-attenders or cervical screening: A randomised controlled trial. British Journal of Cancer, 104, 915-920. http://dx.doi.org/10.1038/bjc.2011.48
[21]	Harper, D.M. (2004) Self-sampling for HPV: What method to use? Today Newsletter of Human Papillomavirus, 5, 12.
[22]	Sankaranarayanan, R. (2011) Prevention of mortality from cervical cancer in rural India: The value of an HPV test. HPV Today Newsletter of Human Papillomavirus, 23, 1-3.